Dr. Sara DuMond
appointed Dr. Sara DuMond to serve on the Board as an “independent” director to fill the vacancy created by that action. The appointment is effective October 21, 2024.
Highest-materiality recent filing
United Bankshares posts record FY2025 earnings of $464.6M ($3.27 EPS); Q4 EPS $0.91
Record annual net income $464.6M ($3.27 EPS) in FY2025, up 24.5% from FY2024's $373.0M ($2.75 EPS).
UBSI reports record Q3 EPS of $0.92; NPLs surge to $117M on two large CRE loans
Q3 net income $130.7M ($0.92 diluted), up from Q2 $120.7M ($0.85) and Q3 2024 $95.3M ($0.70).
United Bankshares posts record Q2 net income of $120.7M, diluted EPS $0.85
Net income of $120.7M ($0.85 EPS) vs $96.5M ($0.71) in Q2 2024, up 25% YoY.
United Bankshares Q1 EPS $0.59; record NII $260.1M, Piedmont deal closed
Net income $84.3M ($0.59 diluted EPS) vs. $86.8M ($0.64) Q1 2024; revenue up on Piedmont acquisition.
United Bankshares Q4 EPS $0.69, full-year $2.75; closes $2.4B asset acquisition of Piedmont
Q4 2024 net income $94.4M ($0.69 diluted EPS) vs $0.59 in Q4 2023; full-year $373.0M ($2.75) vs $366.3M ($2.71).
United Bankshares completes acquisition of Piedmont Bancorp; combined assets >$32B
Each Piedmont share converted into 0.300 share of UBSI common stock plus cash for fractional shares.
UBSI receives all regulatory approvals for Piedmont Bancorp merger; closing expected early 2025
Federal Reserve Board approval received Nov 29, 2024; state banking approvals already in hand.
United Bankshares Q3 EPS $0.70; net income $95.3M, down slightly YoY; Piedmont merger on track
Diluted EPS $0.70 vs $0.71 YoY and QoQ; net income $95.3M, down from $96.2M in Q3 2023.
United Bankshares Q2 EPS $0.71 beats Q1 and YoY; NIM expands; Piedmont merger on track
Q2 net income $96.5M ($0.71 diluted EPS) vs $86.8M ($0.64) in Q1 and $92.5M ($0.68) in Q2 2023.
United Bankshares to acquire Piedmont Bancorp for ~$267M in stock
United will acquire all Piedmont shares at 0.300x UBSI shares; total consideration ~$267M.
United Bankshares Q1 2024 net income $86.8M ($0.64 EPS), down from $0.73 YoY
Net income $86.8M vs $98.3M in Q1 2023 and $79.4M in Q4 2023; diluted EPS $0.64.
appointed Dr. Sara DuMond to serve on the Board as an “independent” director to fill the vacancy created by that action. The appointment is effective October 21, 2024.
Max materiality 0.85 · Median 0.60 · Most common event earnings